Kirkland & Ellis and Arnold & Porter Kaye Scholer LLP have advised Curium. Covington & Burling LLP and Ropes & Gray LLP have advised Lantheus. Curium...
Curium to Acquire Lantheus in $8 Billion Merger
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction
Skadden and NautaDutilh N.V. have advised CureVac. Covington & Burling LLP, Hengeler Mueller Partnerschaft von Rechtsanwälten mbB and Loyens & Loeff N.V. have advised BioNTech. BioNTech...
Lantheus’ $750 Million Acquisition of Life Molecular Imaging
Covington & Burling advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (Nasdaq: LNTH) (Lantheus) announced its definitive agreement to acquire Life Molecular Imaging Limited,...
Getinge’s $477 Million Acquisition of Paragonix Technologies
Covington & Burling represented Getinge in the transaction. Getinge announced its acquisition of Paragonix Technologies, Inc., a leading organ transport products and services company in the...
Selecta Biosciences’ Merger with Cartesian Therapeutics
Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics. Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent...
NewAmsterdam Pharma’s DeSPAC Merger with Frazier Lifesciences
Covington and NautaDutilh advised NewAmsterdam Pharma on the deal, while Latham & Watkins advised Lincoln International. Houthoff assisted Frazier Lifesciences Acquisition Corp. NewAmsterdam Pharma Holding B.V.,...